Cheelcare Stock Price, News & Analysis

Cheelcare Inc. designs and manufactures advanced mobility solutions for people with disabilities. The company’s publicly traded securities are associated with TSXV symbol CHER and OTC symbol CHCRF, and its business is centered on powered mobility products that combine rehabilitation equipment, assistive technology, and human-centered engineering.

The company’s product portfolio includes the Companion power assist device line and the Curio robotic complex-rehab power wheelchair. Companion is designed as a power-assist product for mobility users, while Curio represents Cheelcare’s complex-rehabilitation power wheelchair platform. Company updates describe commercial activity around Companion bookings and sales, dealer and clinician engagement, reimbursement-supported access, and the transition of Curio into commercial production and initial paying-customer deliveries.

Cheelcare operates as a healthcare equipment and mobility technology manufacturer. Its commercial model includes manufacturing mobility devices, selling through dealer networks, and supporting product adoption through reimbursement, clinical, therapist, dealer, and funding-agency channels. The Companion platform has received U.S. Medicare and Medicaid reimbursement eligibility through PDAC verification, which supports insurance-funded access in the United States and is a recurring theme in the company’s commercial updates.

The company is based in Markham, Ontario, Canada. Cheelcare’s operating priorities described in company materials include production scale-up, supply chain control, dealer-network expansion, product manufacturing, working capital support, and quality and regulatory systems for mobility-device production. Its public-company updates also cover financial results, product bookings, request-for-quotation activity, note financing, and participation in healthcare investor conferences.